Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Regulator of DNA class I crossover intermediates 1 (REDIC1) is a protein essential for meiotic crossover formation in mammals. It acts during meiosis to stabilize recombination intermediates, particularly by binding branched DNA structures such as D-loops and Holliday junctions. Loss-of-function mutations in REDIC1 cause dramatic defects in meiotic progression, loss of class I crossovers, and infertility due to meiotic arrest. The gene is most highly expressed in germ cells (testis, fetal ovary) and is conserved among mammals. While not a therapeutic target or classical receptor/enzyme, REDIC1 plays a crucial, specific role in germline recombination and fertility regulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regulator of DNA class I crossover intermediates 1 (REDIC1).